Alveolar rhabdomyosarcoma in a 68-year-old patient identified by cytogenetic analysis of bone marrow

Cancer Genetics and Cytogenetics

Volumn 107, Issue 1, 1998, Pages 43-47

  Stindl, Reinhard ^a   Fiegl, Michael ^b   Regele, Heinz ^a   Gisslinger, Heinz ^b   Breitenseher, Martin J ^c   Fonatsch, Christa ^a  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c UNIV KLIN FÜR RADIODIAGNOSTIK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GENETICS; CASE REPORT; CHROMOSOME 13Q; CHROMOSOME 1Q; CHROMOSOME 2Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME TRANSLOCATION 13; CHROMOSOME TRANSLOCATION 2; DISSEMINATED INTRAVASCULAR CLOTTING; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; ISOCHROMOSOME; PANCYTOPENIA; PRIORITY JOURNAL; RHABDOMYOSARCOMA; TETRAPLOIDY;

AGED; BONE MARROW EXAMINATION; CERVICAL VERTEBRAE; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 2; FATAL OUTCOME; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GENETIC MARKERS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; RHABDOMYOSARCOMA, ALVEOLAR; SPINAL NEOPLASMS; TRANSLOCATION, GENETIC;

POMACANTHUS MACULOSUS;

EID: 0032212650     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(98)00061-2     Document Type: Article

References (23)

1. 1. Enzinger FM, Shiraki M (1969): Alveolar rhabdomyosarcoma: an analysis of 100 cases. Cancer 24:18-31.
2. 2. Seidal T, Mark J, Hagmar B, Angervall L (1982): Alveolar rhabdomyosarcoma: a cytogenetic and correlated cytological and histological study. Acta Pathol Microbiol Immunol Scand A 90:345-354.
3. 3. Turc-Carel C, Lizard-Nacol S, Justrabo E, Favrot M, Philip T, Tabone E (1986): Consistent chromosomal translocation in alveolar rhabodmyosarcoma. Cancer Genet Cytogenet 19:361-362.
4. 4. Douglass EC, Valentine M, Etcubanas E, Parham D, Webber BL, Houghton PJ, Houghton JA, Green AA (1987): A specific chromosomal abnormality in rhabdomyosarcoma. Cytogenet Cell Genet 45:148-155.
5. 5. Lizard-Nacol S, Mugneret F, Volk C, Turc-Carel C, Favrot M, Philip T (1987): Translocation (2;13)(q37;q14) in alveolar rhabdomyosarcoma: a new case. Cancer Genet Cytogenet 25:373-374.
6. 6. Wang-Wuu S, Soukup S, Ballard E, Gotwals B, Lampkin B (1988): Chromosomal analysis of sixteen human rhabdomyosarcomas. Cancer Res 48:983-987.
7. 7. Whang-Peng J, Knutsen T, Theil K, Horowitz ME, Triche T (1992): Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosom Cancer 5:299-310.
8. 8. Engel R, Ritterbach J, Schwabe D, Lampert F (1988): Chromosome translocation (2;13)(q37;q14) in a disseminated alveolar rhabdomyosarcoma. Eur J Pediatr 148:69-71.
9. 9. Yule SM, Bown N, Malcolm AJ, Reid MM, Pearson AD (1995): Solid alveolar rhabdomyosarcoma with a t(2;13). Cancer Genet Cytogenet 80:107-109.
10. 10. Rauscher FJ, III, Vogt PK (1997): Chromosomal Translocation and Oncogenic Transcription Factors. Springer, Berlin.
11. 11. Fonatsch C, Schaadt M, Kirchner H, Diehl V (1980): A possible correlation between the degree of karyotype aberrations and the rate of sister chromatid exchanges in lymphoma lines. Int J Cancer 26:749-756.
12. 12. Shapiro DN, Parham DM, Douglass EC, Ashmun R, Webber BL, Newton WA, Jr, Hancock ML, Maurer HM, Look AT (1991): Relationship of tumor-cell ploidy to histologic subtype and treatment outcome in children and adolescents with unresectable rhabdomyosarcoma. J Clin Oncol 9:159-166.
13. 13. Enzinger FM, Weiss SW (1995): Soft Tissue Tumors. Mosby-Year Book, St. Louis.
14. 14. Mitelman F (1994): Catalog of Chromosome Aberrations in Cancer. Wiley-Liss, New York.
15. 15. Fredericks WJ, Galili N, Mukhopadhyay S, Rovera G, Bennicelli J, Barr FG, Rauscher FJ, III (1995): The PAX3-FKHR fusion protein created by the t(2;13) translocation in alveolar rhabdomyosarcomas is a more potent transcriptional activator than PAX3. Mol Cell Biol 15:1522-1535.
16. 16. Ambrosiani L, Bellone S, Betto FS, Cecchetti G, Ceretti E, Dagani R, Morelli A, Pavia G, Schiaffino E, Tavani E, Vismara A (1996): Rhabdomyosarcoma presenting as acute hematologic malignancy: case report and review of the literature. Tumori 82:408-412.
17. 17. Eldor A, Naparstek E, Boss JH, Biran S (1977): Alveolar rhabdomyosarcoma presenting as subacute intravascular coagulation. J Clin Pathol 30:661-665.
18. 18. Fitzmaurice RJ, Johnson PR, Yin JA, Freemont AJ (1991): Rhabdomyosarcoma presenting as "acute leukemia." Histopathology 18:173-175.
19. 19. Putti MC, Montaldi A, D'Emilio A, Sainati L, Milanesi C, Stella M, Zanesco L, Basso G (1991): Unusual leukemic presentation of rhabdomyosarcoma: report of two cases with immunological, ultrastructural and cytogenetical studies. Haematologica 76:368-374.
20. 20. Ruymann FB, Newton WA, Jr, Ragab AH, Donaldson MH, Foulkes M (1984): Bone marrow metastases at diagnosis in children and adolescents with rhabdomyosarcoma: a report from the intergroup rhabdomyosarcoma study. Cancer 53:368-373.
21. 21. Reid MM, Saunders PW, Bown N, Bradford CR, Maung ZT, Craft AW, Malcolm AJ (1992): Alveolar rhabdomyosarcoma infiltrating bone marrow at presentation: the value to diagnosis of bone marrow trephine biopsy specimens. J Clin Pathol 45:759-762.
22. 22. Gordon SG (1992): Cancer cell procoagulants and their implications. Hematol Oncol Clin North Am 6:1359-1374.
23. 23. Seidal T, Kindblom LG, Angervall L (1989): Rhabdomyosarcoma in middle-aged and elderly individuals. APMIS 97:236-248.